ERYTHROMYCIN OPHTHALMIC OINTMENT USP 5 MG
ERYTHROMYCIN : 5 MG · DIN 02326663 · STERI-MED PHARMA INC.
Health Canada status: MARKETED
What is ERYTHROMYCIN OPHTHALMIC OINTMENT USP?
ERYTHROMYCIN OPHTHALMIC OINTMENT USP 5 MG contains ERYTHROMYCIN : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02326663, held by STERI-MED PHARMA INC., supplied as OINTMENT for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 07-Apr-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ERYTHROMYCIN OPHTHALMIC OINTMENT USP used for?
Treatment of superficial ocular infections (conjunctiva/cornea) caused by susceptible organisms. Prophylaxis of ophthalmia neonatorum due to N. gonorrhoeae or C. trachomatis.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02326663 |
|---|---|
| Brand name | ERYTHROMYCIN OPHTHALMIC OINTMENT USP |
| Generic / active ingredient | ERYTHROMYCIN : 5 MG |
| Manufacturer | STERI-MED PHARMA INC. |
| Strength | 5 MG |
| Dosage form | OINTMENT |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01AA17 ERYTHROMYCIN |
| AHFS class | 52:04.04 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 07-Apr-2022 |
| Original market date | 2010-02-12 00:00:00 |
How is it administered?
External ocular infections: apply one or more times daily. Neonatal prophylaxis: 0.5 to 1 cm ribbon into each conjunctival sac. Do not flush from eye.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at room temperature (15-30°C). Protect from freezing. Keep tightly closed.
How is it supplied?
Tubes of 3.5 g and unit dose tubes of 1 g in boxes of 50.
Contraindications
Known hypersensitivity to erythromycin or its derivatives or any ingredient in the formulation; infections resistant to the drug (primarily certain Staphylococci).
Warnings and precautions
Risk of superinfection by non-susceptible bacteria or fungi with prolonged use. Use only for proven/suspected bacterial infections to avoid drug resistance. Remove contact lenses before use.
Is ERYTHROMYCIN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by PHARMA STULLN INC. (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code S01AA17 ERYTHROMYCIN. 3 of 9 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ERYTHROMYCIN | 5 MG | OINTMENT | PHARMA STULLN INC. | MARKETED | DIN 02141574 |
| PDP-ERYTHROMYCIN | 5 MG | OINTMENT | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 01912755 |
| ERYMYCIN OPHTHALMIC OINTMENT 5MG/G | 5 MG | OINTMENT | MM THERAPEUTICS INC | CANCELLED POST MARKET | DIN 02237041 |
| ERYTHROMYCIN OPHTHALMIC OINTMENT U.S.P. | 5 MG | OINTMENT | RIVEX OPHTHALMICS INC. | CANCELLED POST MARKET | DIN 02212935 |
| EURO-ERYTHROMYCIN OPHTHALMIC OINTMENT USP | 5 MG | OINTMENT | EURO-PHARM INTERNATIONAL CANADA INC | CANCELLED PRE MARKET | DIN 02460211 |
| ILOTYCIN CRYST OP ONT 0.5% 52 | .5 % | OINTMENT | ELI LILLY CANADA INC | CANCELLED POST MARKET | DIN 00015970 |
| ODAN-ERYTHROMYCIN | 5 MG | OINTMENT | ODAN LABORATORIES LTD | DORMANT | DIN 00641324 |
| PMS-ERYTHROMYCIN | 5 MG | OINTMENT | PHARMASCIENCE INC | APPROVED | DIN 02492350 |
Who else supplies ERYTHROMYCIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ERYTHROMYCIN appears in 767 registered pack listings across 11 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.